Health In Tech, Stock Performance
| HIT Stock | 1.53 0.01 0.66% |
The company retains a Market Volatility (i.e., Beta) of 0.023, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Health In's returns are expected to increase less than the market. However, during the bear market, the loss of holding Health In is expected to be smaller as well. At this point, Health In Tech, has a negative expected return of -1.02%. Please make sure to check out Health In's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Health In Tech, performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Health In Tech, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 2.4 M | |
| Total Cashflows From Investing Activities | -836.8 K |
Health In Relative Risk vs. Return Landscape
If you would invest 352.00 in Health In Tech, on September 28, 2025 and sell it today you would lose (199.00) from holding Health In Tech, or give up 56.53% of portfolio value over 90 days. Health In Tech, is generating negative expected returns assuming volatility of 7.5899% on return distribution over 90 days investment horizon. In other words, 68% of stocks are less volatile than Health, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Health In Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health In's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Health In Tech,, and traders can use it to determine the average amount a Health In's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1339
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HIT |
Based on monthly moving average Health In is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Health In by adding Health In to a well-diversified portfolio.
Health In Fundamentals Growth
Health Stock prices reflect investors' perceptions of the future prospects and financial health of Health In, and Health In fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Health Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0533 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 78.64 M | ||||
| Shares Outstanding | 45.21 M | ||||
| Price To Earning | 24.13 X | ||||
| Price To Book | 5.04 X | ||||
| Price To Sales | 2.82 X | ||||
| Revenue | 19.49 M | ||||
| EBITDA | 1.93 M | ||||
| Cash And Equivalents | 7.05 B | ||||
| Cash Per Share | 15.61 X | ||||
| Total Debt | 206.69 K | ||||
| Debt To Equity | 1.14 % | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | 2.18 M | ||||
| Earnings Per Share | 0.02 X | ||||
| Total Asset | 15.77 M | ||||
| Retained Earnings | 3.94 M | ||||
| Current Asset | 59.12 B | ||||
| Current Liabilities | 49.33 B | ||||
About Health In Performance
Assessing Health In's fundamental ratios provides investors with valuable insights into Health In's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Health In is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Hitachi, Ltd. manufactures and sells electronic and electrical solutions primarily in Asia, North America, and Europe.Things to note about Health In Tech, performance evaluation
Checking the ongoing alerts about Health In for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Health In Tech, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Health In Tech, generated a negative expected return over the last 90 days | |
| Health In Tech, has high historical volatility and very poor performance | |
| Health In Tech, may become a speculative penny stock | |
| About 70.0% of the company shares are held by company insiders |
- Analyzing Health In's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Health In's stock is overvalued or undervalued compared to its peers.
- Examining Health In's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Health In's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Health In's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Health In's stock. These opinions can provide insight into Health In's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.